Akoya Biosciences, Inc. (AKYA)
After hours:
- GuruFocus.com
Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Despite a revenue dip, Akoya Biosciences showcases growth in reagent sales and strategic expansions, setting a course for recovery.
- Zacks
Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates
Akoya (AKYA) delivered earnings and revenue surprises of -16.67% and 23.94%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Akoya Biosciences Reports First Quarter 2024 Financial Results
MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the first quarter ending March 31, 2024. Business Highlights Revenue was $18.4 million in the first quarter of 2024, compared to $21.4 million in the prior year period; a decrease of 14%. Reagents and services revenue continued to increase.Akoya announced the establishment of a new Manufacturing Center of Excellence in Marl
